Potential drug–drug interactions and nephrotoxicity in hematopoietic stem cell transplant adult recipients during bone marrow transplantation unit stay-Reference-Cited by-同舟云学术

Potential drug–drug interactions and nephrotoxicity in hematopoietic stem cell transplant adult recipients during bone marrow transplantation unit stay

Published:2019-02-13 Issue:5 Volume:83 Page:827-835
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Sanchez Lydia,Bacle Astrid,Lamy Thierry,Le Corre Pascal^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-019-03791-9/fulltext.html

Reference32 articles.

1. Leather HL (2004) Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know. Bone Marrow Transpl 33:137–152

2. Glotzbecker B, Duncan C, Alyea E 3rd, Campbell B, Soiffer R (2012) Important drug interactions in hematopoietic stem cell transplantation: what every physician should know. Biol Blood Marrow Transpl 18:989–1006

3. Gay C, Toulet D, Le Corre P (2017) Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy. Hematol Oncol 35:259–280

4. Morival C, Oumari S, Lenglet A, Le Corre P (2017) Clinical pharmacokinetics of oral drugs in the treatment of multiple myeloma. Hematol Oncol. https://doi.org/10.1002/hon.2485

5. Riechelmann RP, Saad ED (2006) A systematic review on drug interactions in oncology. Cancer Invest 24:704–712

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic pathways of allogeneic and autologous hematopoietic stem cell transplantation recipients: a hospital pharmacist’s perspective;Ars Pharmaceutica (Internet);2024-06-20

2. Concordance analysis of two databases to search for potential drug interactions in onco-hematologic patients;Journal of Oncology Pharmacy Practice;2024-01-30

3. Impact of Antimicrobial Drug-Drug Interactions on Acute Kidney Injury after Allogeneic Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2023-07

4. Evaluation of the quality of life of adult patients admitted to the bone marrow transplantation unit;Journal of Oncology Pharmacy Practice;2023-04-17

5. Interactions médicamenteuses et incompatibilités physico-chimiques en phase aiguë post-allogreffe : quelle influence des médicaments de support ? Recommandations de la SFGM-TC;Bulletin du Cancer;2023-02